Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1980 1
1987 1
1989 1
1991 1
1992 1
1993 1
1996 6
1997 2
1998 5
1999 4
2000 8
2001 7
2002 10
2003 8
2004 8
2005 3
2006 4
2007 5
2008 6
2009 9
2010 6
2011 21
2012 18
2013 30
2014 25
2015 10
2016 15
2017 10
2018 4
2019 4
2020 7
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 22065352

221 results
Results by year
Filters applied: . Clear all
Page 1
Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.
Gronich N, Lavi I, Rennert G. Gronich N, et al. CMAJ. 2011 Dec 13;183(18):E1319-25. doi: 10.1503/cmaj.110463. Epub 2011 Nov 7. CMAJ. 2011. PMID: 22065352 Free PMC article.
Drospirenone: high risk of venous thrombosis.
[No authors listed] [No authors listed] Prescrire Int. 2011 Feb;20(113):43-5. Prescrire Int. 2011. PMID: 21488592
Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
Dinger J, Bardenheuer K, Heinemann K. Dinger J, et al. Contraception. 2014 Apr;89(4):253-63. doi: 10.1016/j.contraception.2014.01.023. Epub 2014 Feb 4. Contraception. 2014. PMID: 24576793 Clinical Trial.
Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N, Smith KP. Sehovic N, et al. Ann Pharmacother. 2010 May;44(5):898-903. doi: 10.1345/aph.1M649. Epub 2010 Apr 6. Ann Pharmacother. 2010. PMID: 20371756 Review.
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Lidegaard O, Nielsen LH, Skovlund CW, Løkkegaard E. Lidegaard O, et al. BMJ. 2012 May 10;344:e2990. doi: 10.1136/bmj.e2990. BMJ. 2012. PMID: 22577198 Free PMC article.
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.
van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR. van Hylckama Vlieg A, et al. BMJ. 2009 Aug 13;339:b2921. doi: 10.1136/bmj.b2921. BMJ. 2009. PMID: 19679614 Free PMC article.
Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
Seeger JD, Loughlin J, Eng PM, Clifford CR, Cutone J, Walker AM. Seeger JD, et al. Obstet Gynecol. 2007 Sep;110(3):587-93. doi: 10.1097/01.AOG.0000279448.62221.a8. Obstet Gynecol. 2007. PMID: 17766604
Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.
Dinger J, Möhner S, Heinemann K. Dinger J, et al. Contraception. 2016 May;93(5):378-85. doi: 10.1016/j.contraception.2016.01.012. Epub 2016 Jan 26. Contraception. 2016. PMID: 26825258
Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis.
Stegeman BH, de Bastos M, Rosendaal FR, van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Stegeman BH, et al. BMJ. 2013 Sep 12;347:f5298. doi: 10.1136/bmj.f5298. BMJ. 2013. PMID: 24030561 Free PMC article. Review.
221 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback